Allosite Therapeutics, a biotechnology company discovering and developing innovative integrin therapies for kidney diseases and other immunologic conditions, today announced that the company will ...
IBD research, for all its sophistication, has been searching under the lamppost — sequencing, mapping and quantifying what can be seen. But the key may lie in the park, in the unseen intersections of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback